Diabetes and HFE mutations: cause or coincidence?

Affiliations

¹ Department of Medicine, Division of General Internal Medicine, University of Washington Medical Center, 4245 Roosevelt Way, NE Seattle, WA 98105-6920, USA. lpinsky@u.washington.edu

Comment

Linda E Pinsky et al. West J Med. 2002 Mar.

. 2002 Mar;176(2):114-5.

¹ Department of Medicine, Division of General Internal Medicine, University of Washington Medical Center, 4245 Roosevelt Way, NE Seattle, WA 98105-6920, USA. lpinsky@u.washington.edu

No abstract available

Comment on

Should all patients with diabetes mellitus be screened for hemochromatosis?
Henderson PC, Dowling P, Ozaki R. Henderson PC, et al. West J Med. 2002 Mar;176(2):110-4. West J Med. 2002. PMID: 11897733 Free PMC article. Review. No abstract available.

1. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998;114: 319-323. - PubMed
1. Bacon BR. Diagnosis and management of hemochromatosis. Gastroenterology 1997;113: 995-999. - PubMed
1. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000;133: 329-337. - PubMed
1. Beutler E, Felitti V, Gelbart T, Ho NJ, Waalen J. Clinical penetrance of hemochromatosis (HH) is extremely low [abstract]. Presented at the annual meeting of the American Society of Human Genetics, San Diego, CA, October 2001.
1. Bulaj ZJ, Ajioka RS, Phillips JD, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000;343: 1529-1535. - PubMed